Why is medicine especially cancer treatments using such old age classification and not integrating molecular aadvances into the practice of medicine? https://t.co/KalfmacXuG.
Gleason score 6 adenocarcinoma: should it be labeled as cancer?
Mentions
Extended reach
Total likes
Video views
Mentions per month
Nov 2022 – Sep 2025Where it's discussed
-
News22 articles
-
YouTube6 videos
-
Blogs6 articles
-
Facebook2 posts
-
X / Twitter1 posts
AI synopsis
What people are saying
Discussions reflect a concern about the disconnect between outdated classification systems and modern molecular science, exemplified by questions like why medicine continues to use old age classifications instead of incorporating recent advances, with tone ranging from critical to curious. The words and tone indicate an interest in modernizing cancer diagnosis, but the discussion remains at a general level without deep technical engagement.
Some discussions align with the idea that traditional classifications are outdated and need updating, reflecting partial agreement.
The discussion shows moderate curiosity about the integration of new scientific advances into medical practice.
Posts engage by questioning and suggesting improvements, but do not delve deeply into specific clinical or molecular details.
The conversation indicates awareness of broader issues but lacks evidence of significant influence or immediate change.
Abstract in brief
- Gleason score 6 adenocarcinoma is a type of prostate cancer that is generally considered low-grade and less aggressive.
- There is debate whether it should be labeled as "cancer" because it often grows very slowly and might not cause harm during a patient's lifetime.
- Some experts argue calling it "cancer" may lead to unnecessary anxiety and treatment, while others believe proper labeling helps ensure careful monitoring.]
Top posts
Most liked on X and BlueskyAll mentions
Understanding Prostate Cancer Treatments and Their Effectiveness
Whats the truth about prostate cancer treatments. There are many options including surgery, radiation, and focal therapies, but current evidence does not conclusively show they save many lives. The risk of complications…
Evaluating Prostate Cancer Screening: Effectiveness and Limitations
Prostate cancer awareness campaigns often rely on ineffective tests. PSA blood tests and digital rectal exams have high false positive rates and limited reliability, failing to significantly reduce mortality. This video…
Evaluating the Effectiveness and Risks of PSA Screening for Prostate Cancer
Whats the truth about the PSA test? The PSA test is highly unreliable with a high false positive rate and no proven mortality benefit. Most prostate cancers are outlived, and screening may cause more harm than good.
Evaluating Prostate Cancer Screening Accuracy and Limitations
Prostate cancer screening is highly unreliable, with PSA levels often misleading. High false positive rates and inability to distinguish aggressive cancers question its effectiveness in saving lives.
Prostate Health and Cancer Awareness: A Data-Driven Overview
Prostate health refers to the wellbeing of the prostate gland, a crucial organ in male reproductive and urinary health. Prostate cancer awareness programs aim to promote screenings and support, but recent studies…
Understanding Men's Health Month and Prostate Cancer Awareness Strategies
Men's Health Month in June aims to raise awareness of preventable health issues, promote early detection, and encourage healthy lifestyles. It also includes prostate cancer awareness, which focuses on early screening…
Why is medicine especially cancer treatments using such old age classification and not integrating molecular aadvances into the practice of medicine? https://t.co/KalfmacXuG.